Literature DB >> 26216620

Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery.

Dan Shao1, Zheng Wang1,2, Wen-fei Dong2, Xin Zhang1, Xiao Zheng1, Xuan-ang Xiao1, Ying-shuai Wang3, Xue Zhao1, Ming Zhang1, Jing Li1, Qi-sheng Huo4, Li Chen1,5.   

Abstract

The facile synthesis of core-shell magnetic mesoporous silica nanoparticles (Fe3 O4 @mSiO2 NPs) was reported in aqueous phase using cetyltrimethylammonium bromide as a template under alcohol-free conditions. Compared to the conventional synthesis method for core-shell Fe3 O4 @mSiO2 NPs, the approach in this study is rapid (only 5-min reaction time), cheap (without using organic agents), and environmentally friendly (one-step synthesis in alcohol-free medium). Doxorubicin (DOX)-loaded Fe3 O4 @mSiO2 NPs exert extraordinarily high specificity for liver cancer cells, which was due to the pH-sensitive doxorubicin release, as well as higher endocytosis capacity in liver cancer cells rather than normal liver cells. The potential advantages of using such Fe3 O4 @mSiO2 NPs as the vehicle of anticancer drugs were that the Fe3 O4 @mSiO2 NPs exhibit good biocompatibility, high loading and protection of the guest molecules, selective killing effect, and efficient cellular uptake. The exciting pH-dependent release properties of doxorubicin-loaded Fe3 O4 @mSiO2 NPs make their use a promising strategy for enhancing efficient therapy toward tumors, while reducing the cytotoxicity of doxorubicin to human normal neutral tissue or cells.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  core-shell; facile; liver cancer therapy; magnetic mesoporous silica; selective

Mesh:

Substances:

Year:  2015        PMID: 26216620     DOI: 10.1111/cbdd.12622

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  7 in total

Review 1.  pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Bioengineering (Basel)       Date:  2017-01-18

2.  Core-Shell Magnetic Gold Nanoparticles for Magnetic Field-Enhanced Radio-Photothermal Therapy in Cervical Cancer.

Authors:  Rui Hu; Minxue Zheng; Jinchang Wu; Cheng Li; Danqing Shen; Dian Yang; Li Li; Mingfeng Ge; Zhimin Chang; Wenfei Dong
Journal:  Nanomaterials (Basel)       Date:  2017-05-11       Impact factor: 5.076

3.  Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery.

Authors:  Zhengzou Fang; Xinyuan Li; Zeyan Xu; Fengyi Du; Wendi Wang; Ruihua Shi; Daqing Gao
Journal:  Int J Nanomedicine       Date:  2019-07-30

4.  Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.

Authors:  Meng-Meng Lu; Yuran Ge; Jing Qiu; Dan Shao; Yue Zhang; Jing Bai; Xiao Zheng; Zhi-Min Chang; Zheng Wang; Wen-Fei Dong; Chun-Bo Tang
Journal:  Int J Nanomedicine       Date:  2018-11-19

5.  Janus nanocarriers for magnetically targeted and hyperthermia-enhanced curcumin therapy of liver cancer.

Authors:  Hao Xing; Zheng Wang; Dan Shao; Zhimin Chang; Mingfeng Ge; Li Li; Mingdi Wu; Zhuangzhi Yan; Wenfei Dong
Journal:  RSC Adv       Date:  2018-08-29       Impact factor: 4.036

6.  Modified core-shell magnetic mesoporous zirconia nanoparticles formed through a facile "outside-to-inside" way for CT/MRI dual-modal imaging and magnetic targeting cancer chemotherapy.

Authors:  Lufeng Chen; Hongshan Zhong; Xun Qi; Haibo Shao; Ke Xu
Journal:  RSC Adv       Date:  2019-04-30       Impact factor: 4.036

7.  Monte Carlo simulation of physical dose enhancement in core-shell magnetic gold nanoparticles with TOPAS.

Authors:  Xiaohan Xu; Jianan Wu; Zhitao Dai; Rui Hu; Yaoqin Xie; Luhua Wang
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.